Otabe S, Sakura H, Shimokawa K, Mori Y, Kadowaki H, Yasuda K, Nonaka K, Hagura R, Akanuma Y, Yazaki Y
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
J Clin Endocrinol Metab. 1994 Sep;79(3):768-71. doi: 10.1210/jcem.79.3.8077358.
Recently, an A to G transition at position 3243 in transfer ribonucleic acidLeu(UUR) [the 3243 base-pair (bp) mutation] originally found in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes has been identified in patients with diabetes and deafness. To determine the prevalence of the diabetic patients with this mutation in Japan, we screened 550 randomly selected cohorts of diabetic patients without prior information about clinical features such as type of diabetes, family history of diabetes, age of onset, and mode of therapy. We have identified 5 patients with this mutation, suggesting that approximately 0.9% of diabetic patients have the 3243 bp mutation. However, there were no subjects with this mutation in 250 controls with normal glucose tolerance. The percentage of mutant DNA in whole mitochondrial DNA did not correlate to the degree of symptoms. We conclude that the 3243 bp mutation in the mitochondrial gene plays an important part as a cause of diabetes in Japan.
最近,最初在患有线粒体肌病、脑病、乳酸性酸中毒和中风样发作的患者中发现的转运核糖核酸亮氨酸(UUR)第3243位的A到G转换(3243碱基对突变),在糖尿病和耳聋患者中也被发现。为了确定日本患有这种突变的糖尿病患者的患病率,我们对550名随机选择的糖尿病患者队列进行了筛查,这些患者事先没有关于糖尿病类型、糖尿病家族史、发病年龄和治疗方式等临床特征的信息。我们已经确定了5名患有这种突变的患者,这表明约0.9%的糖尿病患者有3243碱基对突变。然而,在250名糖耐量正常的对照者中没有发现有这种突变的受试者。整个线粒体DNA中突变DNA的百分比与症状程度无关。我们得出结论,线粒体基因中的3243碱基对突变在日本作为糖尿病的一个病因起着重要作用。